CClinicalTrials.gg
CompletedNCT02168296Updated Feb 18, 2015

Pharmacokinetics of Plant-based Ingredient

An interventional study of Plant-based ingredient added to starchy meal and Plant-based ingredient added to liquid in Healthy, sponsored by Unilever R&D. Completed at 1 site in France. Open to male participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-02-18.

Sponsored by Unilever R&D · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
Male
01

Study summary

The study is designed to explore the pharmacokinetics of a Plant-based ingredient in two different matrices, at different dose levels.

02

Conditions studied

  • Healthy

Keywords

  • Pharmacokinetics
  • Blood glucose
  • subjects
03

In context

Lead sponsor

Unilever R&D is the lead sponsor of 69 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy males, age at start of the study 20 and 50 years
  • Body mass index (BMI) ≥ 20,0 and ≤ 25,0 kg/m2
  • Apparently healthy: no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases)
  • Fasting blood glucose value of subjects is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening

Exclusion criteria

Exclusion Criteria:

  • Any history of diabetes, hyper- (or hypo-) glycemia or other disorder of glucose metabolism
  • Any history of gastro-intestinal disorders (including frequent diarrhoea for example)
  • Blood donation in the past 2 months
  • Reported participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study
  • Reported intense sporting activities > 10 h/w
  • Consumption of > 21 alcoholic drinks in a typical week
  • Not being used to eat breakfast
  • Reported use of any nicotine containing products in the six months preceding the study and during the study itself
  • Use of medication which interferes with study measurements
  • Reported dietary habits: medically prescribed diet, slimming diet
  • Not used to eat 3 meals a day
  • Vegetarian
  • Reported weight loss/gain (>10%) in the last six month before the study;
  • Allergy or intolerance to food products and aversion to food products;
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
20 participants (actual)

Study arms

  • Placebo comparator
    No added Plant-based ingredient

    No Plant-based ingredient added to starchy meal

    Dietary Supplement: No Plant-based ingredient

  • Active comparator
    Low dose added to starchy meal

    Plant-based ingredient in low dose added to starchy meal

    Dietary Supplement: Plant-based ingredient added to starchy meal

  • Active comparator
    High dose added to starchy meal

    Plant-based ingredient in high dose added to starchy meal

    Dietary Supplement: Plant-based ingredient added to starchy meal

  • Active comparator
    Low dose added to liquid

    Plant-based ingredient in low dose added to liquid

    Dietary Supplement: Plant-based ingredient added to liquid

  • Active comparator
    High dose added to liquid

    Plant-based ingredient in high dose added to liquid

    Dietary Supplement: Plant-based ingredient added to liquid

Interventions

  • Dietary supplementPlant-based ingredient added to starchy meal
  • Dietary supplementPlant-based ingredient added to liquid
  • Dietary supplementNo Plant-based ingredient
06

What researchers measure

Primary outcomes

  1. AUC of the plant based ingredient calculated by a non-compartmental model

    Time frame: predose, 15min, 30min, 45min, 1h, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.

Secondary outcomes

  1. AUC of the plant based ingredient calculated by a compartmental model

    Time frame: predose, 15min, 30min, 45min, 1hr, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.

  2. Urinary excretion of Plant-based ingredient

    Time frame: 24 hours

Other outcomes

  1. AUC of the plant based ingredient calculated by a population model

    Time frame: predose, 15min, 30min, 45min, 1hr, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.

  2. Describe the time course of the effect on glucose and insulin levels in response to the intake of plant based ingredient

    Time frame: predose, 15min, 30min, 45min, 1hr, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.

  3. +iAUC Blood glucose

    Time frame: 120 minutes and 180 minutes

  4. +iAUC Insulin

    Time frame: 120 minutes and 180 minutes

07

Study locations

1 site
  • Eurofins OPTIMED
    Giere, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02168296
Lead sponsor
Unilever R&D
Responsible party
Sponsor
First posted
Jun 20, 2014
Start date
Jun 2014
Primary completion
Oct 2014
Completion
Oct 2014
Last update
Feb 18, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion